baber/WOPTO huggingface dataset:
Patent CA-2488036-A1 (CA)
Title: Doppler type ultrasonic flowmeter, method of operation and flow rate measuring method
Inventor: MORI MICHITSUGU
IPC: G01F1/66
Filed: 2003-06-03
Abstract: A doppler ultrasonic flowmeter 10A includes: a Udflow unit 13 for calculating the speed of a great number of reflectors 25 contained in a fluid 12 to be measured; a flow-speed distribution calculating element 70 for calculating the flow-speed distribution of the fluid 12 to be measured within a fluid tube 11 by performing computation processing for the flow-speed data of the reflectors 25 received from the Udflow unit 13; a center position detecting element 71 for detecting the center position of the fluid tube 11; a flow-speed distribution calculating member 67 having an area selecting element 72 which allows the user to select a division area within the fluid tube 11 in units of the division area; the flow-speed distribution being calculated for the selected division area using the reflectors 25; and a flow calculating member 68 for measuring the flow by further performing computation processing for the flow-speed distribution of the fluid 12 to be measured. Furthermore, the doppler ultrasonic flowmeter 10A includes a display monitor 39 for displaying the calculation results output from at least one of the flow-speed distribution calculating member 67 and the flow calculating member 68. The present invention having such a configuration provides a doppler ultrasonic flowmeter, a flow measurement method, and a flow measurement program, having the advantage of enabling measurement of the flow-speed distribution and measurement of the flow, regardless of irregularities in the measurement results of the flow-speed distribution.
Patent CA-2488304-A1 (CA)
Title: Multi-stage fuel deoxygenator
Inventor: VANDERSPURT THOMAS H
IPC: B01D71/36
Filed: 2004-11-23
Abstract: A fuel delivery system for an energy conversion device includes a fuel deoxygenator and an oxygen scavenger module for removing dissolved oxygen and increasing the usable cooling capability of a fuel. Fuel emerging from the fuel-deoxygenating device flows into the oxygen-scavenging module where a second portion, smaller than the first portion of oxygen is removed from the fuel.  The combination of the oxygen scavenger and the fuel deoxygenator provides an increase in removal of dissolved oxygen relative to the use of either device alone. The combination provides the desired increase in deoxygenation of fuel without the corresponding increase in device size.
Patent CA-2488953-A1 (CA)
Title: Freeze protection device for wall hydrants/faucets
Inventor: BALL WILLIAM T
IPC: E03B9/14
Filed: 2004-12-03
Abstract: A freezeless wall hydrant has a fluid inlet end connected to a source of pressurized water, and a fluid outlet end. A check valve is placed in the bore of the valve body and is spring loaded to open only when extreme water pressure within the inlet valve lifts a spring loaded piston element to permit the highly pressurized water to move through the bore in the valve body and be relieved as it escapes rearwardly into the original source of pressurized water.
Patent CA-2489428-A1 (CA)
Title: Cyclooxygenase-2 selective inhibitors, compositions and methods of use
Inventor: GARVEY DAVID S
IPC: C07D231/12
Filed: 2003-06-25
Abstract: The invention describes novel cyclooxygenase 2 (COX-2) selective inhibitors and novel compositions comprising at least one cyclooxygenase 2 (COX-2) selective inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitri c oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent . The invention also provides novel kits comprising at least one COX-2 selecti ve inhibitor, optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor, and/or, optionally, at least one therapeutic agent. The novel cyclooxygenase 2 selective inhibitors of the invention can be optionally nitrosated and/or nitrosylated. The invention also provides metho ds for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 selective inhibitors; for facilitating wound healing; for treating and/or preventing renal and/or respiratory toxicity; for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2; and for improving the cardiovascular profile of COX-2 selective inhibitors.
Patent CA-2491805-A1 (CA)
Inventor: LEISSNER PHILIPPE
IPC: C12N15/86
Filed: 2003-07-10
Abstract: The present invention concerns a modified adenoviral fiber containing at least one mutation affecting one or more amino acid residue(s) of said adenoviral fiber interacting with at least one glycosaminoglycan and/or sialic acid-containing cellular receptor, as well as a trimer of such a modified adenoviral fiber. The present invention also relates to a DNA fragment, an expression vector encoding said modified adenoviral fiber. The present invention also concerns an adenoviral particle lacking a wild-type fiber and comprising the trimer of modified adenoviral fibers as well as a process for producing such an adenoviral particle. Theto present invention also provides a composition comprising such an adenoviral particle and the therapeutic use thereof.
Patent CA-2492941-A1 (CA)
Title: Remedy
Inventor: SAGAWA HIROAKI
IPC: A23L1/30
Filed: 2003-07-17
Abstract: A remedy or a preventive for diseases with a need for the enhanced productio n of nerve growth factor (NGF) for the treatment or prevention thereof, an NGF production enhancer and a food, a drink or a feed for enhancing NGF producti on each containing as the active ingredient a compound selected from the group consisting of soyasaponin compounds, soyasapogenin compounds, glycyrrhizin a nd salts thereof; and novel soyasaponin compounds and soyasapogenin compounds having an effect of enhancing NGF production.
Patent CA-2493953-A1 (CA)
Inventor: CAIN JOSEPH BIBB
IPC: H04L12/56
Filed: 2003-04-28
Abstract: La présente invention concerne un procédé d'envoi de données dans un réseau ad-hoc mobile comprenant une pluralité de noeuds et une pluralité de liaisons sans fil reliant les multiples noeuds. Le procédé peut consister à grouper les multiples noeuds en grappes de noeuds (41) et à désigner un noeud principal (42) pour chaque grappe. De plus, une demande d'itinéraire au niveau des grappes peut être envoyée par un noeud source d'une grappe source à un noeud principal de la grappe source (43). Le procédé peut également déterminer une demande d'itinéraire au niveau des grappes entre la grappe source et une grappe de destination, qui comprend un noeud de destination réagissant à une demande d'itinéraire au niveau des grappes et au moyen d'une pluralité de noeuds principaux de grappes. Des données peuvent, en outre, être transférées d'un noeud source à un noeud de destination au moyen de l'itinéraire au niveau des grappes.
Patent CA-2495454-A1 (CA)
Title: Pharmaceutical compositions for inhalation containing a new anticholinergic in conjunction with corticosteroids and betamimetics
Inventor: PIEPER MICHAEL PAUL
IPC: A61K31/167
Filed: 2003-07-25
Abstract: The invention relates to novel medicament compositions based on a novel anticholinesterase drug, corticosteroids and betamimetic drugs, to methods for the production thereof, and to their use in the treatment of respiratory illnesses.
Patent CA-2495881-A1 (CA)
Inventor: ROSENBAUM DANIEL M
IPC: C12Q1/68
Filed: 2003-08-19
Abstract: La nature développe des molécules biologiques telles que des protéines par des séries répétées de diversification, de sélection et d'amplification. La puissance de la nature et la flexibilité de la synthèse organique sont combinées dans une synthèse à matrice d'acide nucléique. La présente invention concerne différentes architectures de matrice permettant de réaliser une synthèse à matrice d'acide nucléique, des méthodes permettant d'augmenter la sélectivité des réactions à matrice d'acide nucléique, des méthodes permettant d'effectuer des réactions stéréosélectives à matrice d'acide nucléique, des méthodes permettant de sélectionner des produits de réaction issus de la synthèse à matrice d'acide nucléique ainsi que des méthodes permettant d'identifier de nouvelles réactions chimiques sur la base d'une synthèse à matrice d'acide nucléique.
Patent CA-2498105-A1 (CA)
Inventor: KIRCHHOFF INGO
IPC: G01R31/34
Filed: 2003-09-05
Abstract: The invention relates to a method and device for detecting spark activity in an electric machine. The shaft voltage (Us(t)) and/or the shaft current (Is(t)) are measured and characteristic components are analyzed in order to detect spark activity. The inventive method, which utilizes respective shaft currents which are mainly considered to be harmful, is precise and suitable for long-term monitoring of spark activities such as sparking, spark erosion, and spark discharges between parts of shaft bearings. Said method can be carried out in a constructively simple and reliable manner using available earthing devices.
Patent CA-2500053-A1 (CA)
Inventor: PASLASKI JOEL S
IPC: G02B6/36
Filed: 2003-08-29
Abstract: An optical apparatus comprises a substrate (921), first and second transmission optical elements (920a, 920b) on the substrate, and an optical component (300) and focusing optical elements (220a, b) on the substrate between the transmission elements.
Patent CA-2500133-A1 (CA)
Title: Polyolefin isolation membrane
Inventor: FRANC ALAN
IPC: E04F15/18
Filed: 2003-09-22
Abstract: This invention relates to an isolation gasket intended to reduce the damage and wear of finishing layers, such as ceramic tiles, when installed over a rigid support layer, such as concrete. The disclosed isolation gasket prevents the propagation of cracks that may develop in the supporting layer through to the finishing layer. A preferred isolation gasket is a low~-density, crosslinked polyolefin foam having a density of from about 60 kg/m3 to about 200 kg/m3, a compressive strength of from about 1/5 kg/cm2 to about 8 kg/cm2, a shear strength of at least 2 mm, and a thickness of at least 0.5 mm.
Patent CA-2500229-A1 (CA)
Inventor: ECKER ROBERT M
IPC: A61N1/372
Filed: 2003-09-19
Abstract: La présente invention a trait à un système de communication de dispositif médical implantable effectuant une communication d'information entre un dispositif médical et au moins un dispositif asservi à travers un bus bifilaire. Les dispositifs asservis peuvent inclure des télécapteurs et autre dispositifs médicaux implantables. Le dispositif médical implantable comprend une unité de communication pour la combinaison de données et d'énergie pour la transmission sur le bus bifilaire. Le signal transmis peut être sélectivement modifié entre une première et une deuxième tension. Le dispositif asservi comprend une unité de récupération pour la récupération de données et d'énergie à partir du signal reçu. Un ensemble de commande extensible inclut de longues commandes pour l'établissement du système et de commandes plus courtes pour la conservation d'énergie. Des commandes à destination multiple d'adressage sélectif, et des commandes de détente rapide abrégées conservent l'énergie en abaissant le courant de système et en augmentant la quantité de données.
Patent CA-2502506-A1 (CA)
Title: Device for dispensing medicine
Inventor: YUYAMA SHOJI
IPC: A61J7/00
Filed: 2003-06-09
Abstract: A device for dispensing medicine comprising a device body, a cassette (2) fixedre movably to the device body in order to contain medicines (D) while arranging, and means (18) for pushing out the medicines (D) in the cassette (2) toward one end side. The cassette (2) comprises a cover (6) and a stopping/receiving part disposed internally in the longitudinal direction. The pushing means (18) comprises a part contained in the cassette (2) and abutting against the medicines (D), a part for urging the abutting part against the medicine, and a part stopping at the stopping/receiving part of the cassette (2) only when the cover (6) is opened. The cassettes (2) can be arranged at a high density and a desired number of medicines can be dispensed surely.
Patent CA-2507586-A1 (CA)
Inventor: DINH CONG THANH
IPC: H02G3/08
Filed: 2005-05-17
Abstract: An outlet box assembly includes an outer faceplate having an interior opening.  An inner faceplate is connected to the outer faceplate such that the inner faceplate is recessed from the outer faceplate and access to the inner faceplate is provided through the interior opening. The inner faceplate has an outlet port and a communication port. The outlet box assembly further includes a support housing having an inner surface and an interior region bounded by the inner surface. The support housing is connected to a rear surface of the inner faceplate such that the outlet port provides access to the interior region. The support housing is configured to allow insertion of an electrical receptacle into the interior region and to provide an enclosure for the electrical receptacle.
Patent CA-2507980-A1 (CA)
Title: Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands
Inventor: CAMARGO ANTONIO
IPC: A61K35/58
Filed: 2003-12-09
Abstract: The present invention is characterized by the process of preparation of pharmaceutical compositions for the development of applications of the Evasins and their structural and/or conformational analogues in chronic-degenerative diseases. It s further characterized by the process of preparation of pharmaceutical compositions and related products of the Evasins peptides and their structural and/or conformational analogues in using the cyclodextrins, its derivatives, liposomes and biodegradable polymers and/or mixture of these systems.The present invention is also characterized by the identification of new biochemical and physio-pharmacological mechanisms not related to the effects on the bradykinin metabolism and angiotensin II formation, which contributes for the mechanism of action of these peptides in chronic-degenerative disorders. In the state-of-art no application was found which uses the Evasins and their analogues included in the cyclodextrins, liposomes, the biodegradable polimers and their derivatives, for the study and treatment of hypertension or other cardiovascular or chronic-degenerative diseases. This characterizes the present invention as a new and more efficient alternative for the study and treatment of these pathologies and their complications.It is further characterized by the increased efficacy of these peptides and their analogues included in cyclodextrins, when administered to rats. This characterizes an increased biodisponibility of these peptides and their analogues using the compositions of the present invention.
Patent CA-2514090-A1 (CA)
Title: Use of glutathione synthesis stimulating compounds in reducing insulin resistance
Inventor: MACEDO PAULA
IPC: A61K31/425
Filed: 2003-01-27
Abstract: There is provided a method of reducing insulin resistance in a mammalian patient comprising selecting a patient suffering from insulin resistance and administering a compound which increases hepatic glutathione and a compound which increases hepatic nitric oxide.
Patent CA-2516024-A1 (CA)
Inventor: PELLACANI LUIGI
IPC: C08G18/48
Filed: 2004-02-06
Abstract: L'invention concerne un prépolymère à base de MDI et à terminaison isocyanate apte à la préparation d'un polymère polyuréthanne hydrophile. La composition à base de MDI comprend un prépolymère obtenu en faisant réagir un mélange isocyanate contenant du 2,4'-méthylène diphénylisocyanate (MDI) et du 4,4'-méthylène diphénylisocyanate dans un rapport molaire allant de 25:75 à 80:20 avec un polyéther polyol dont la teneur minimale en oxyéthylène est de 30 % en poids.
Patent CA-2517485-A1 (CA)
Inventor: LIBENZI DAVIDE
IPC: H04W88/02
Filed: 2004-04-05
Abstract: A system, method and computer program product are provided for accessing security or content analysis functionality utilizing a mobile communication device. Included is an operating system installed on a mobile communication device capable of communicating via a wireless network. Further provided is an application program installed on the mobile communication device and executed utilizing the operating system for performing tasks. A scanning subsystem remains in communication with the application program via an application program interface. Such scanning subsystem is adapted for accessing security or content analysis functionality in conjunction with the tasks performed by the application program.
Patent CA-2518852-A1 (CA)
Title: Monocyclic anilide spirohydantoin cgrp receptor antagonists
Inventor: THEBERGE CORY R
IPC: C07D235/02
Filed: 2004-03-10
Abstract: The present invention is directed to compounds that are antagonists of CGRP  receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache.  The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
Patent CA-2518967-A1 (CA)
Title: Systems and methods for termination of session initiation protocol
Inventor: DOBBINS JAMES R
IPC: G06F15/173
Filed: 2004-04-12
Abstract: Systems (100) for graceful termination of support for session initiation protocol communications on a server (102,104,106 and 108). Systems include means for setting a time period for gracefully terminating such support, means for sending a service unavailable message to a client (110,112,114 and 116), means for causing the server to maintain support, until no later than the expiration of the time period for terminating support, for uncompleted session initiation protocol invites accepted by the server before sending the service unavailable message to the client, and means for terminating support for session initiation protocol communications on the server no later than upon expiration of the time period for terminating support. Methods for graceful termination of such support. Computer-readable media whose contents cause a computer system to perform a graceful termination of such support.
Patent CA-2520343-A1 (CA)
Title: Portable and adjustable boat dock bumper assembly
Inventor: GRIFFEN SCOTT RICHARD
IPC: E02B3/26
Filed: 2005-09-21
Abstract: A boat docket bumper assembly designed to be clamped to a boat dock to protect a boat from coming in direct contact with the dock. The boat dock bumper assembly includes a vertical support to one side of which the a bumper can be attached. The assembly has a mounting member that when combined with suitable clamps, provides for attachment of the assembly to the edge of a dock regardless of its height. The vertical support may include a plurality of holes which provide for adjustability of the height of the bumper or it may include slots with adjustable tie bars to which the bumper can be attached..
Patent CA-2523393-A1 (CA)
Title: Product transport system for a vending machine
Inventor: COLLINS BRYAN ALAN
IPC: G07F11/00
Filed: 2005-10-14
Abstract: A product delivery system for a vending machine includes first and second guide rails and a carnage rail. The guide rails are fixedly mounted in the vending machine spaced from and parallel to each other and extend along respective first and second axes. The carriage rail extends along a third axis and includes first and second ends that are slidably connected to the respective ones of the first and second guide rails. A carrier member is slidably mounted to the carriage rail for movement along the third axis. A first drive belt is coupled to the carriage rail and a first drive motor to selectively shift the carrier membe r along the third axis. A second drive belt, extending in multiple axes, is connected to each of the first and second ends of the carriage rail and a second drive motor. The second drive motor selectively shifts the carriage rail along the first and second axes upon driving the second drive belt.
Patent CA-2523883-A1 (CA)
Title: Antisolvent solidification process
Inventor: GEERTMAN ROBERT MICHAEL
IPC: A61K9/16
Filed: 2004-04-28
Abstract: The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).
Patent CA-2523994-A1 (CA)
Inventor: GUILLORN MICHAEL A
IPC: C23C16/04
Filed: 2004-04-06
Abstract: Systems and methods are described for parallel macromolecular delivery and biochemical/electrochemical interface to whole cells employing carbon nanostructures including nanofibers and nanotubes. A method includes providing a first material on at least a first portion of a first surface of a first tip of a first elongated carbon nanostructure; providing a second material on at least a second portion of a second surface of a second tip of a second elongated carbon nanostructure, the second elongated carbon nanostructure coupled to, and substantially parallel to, the first elongated carbon nanostructure; and penetrating a boundary of a biological sample with at least one member selected from the group consisting of the first tip and the second tip.
Patent CA-2525100-A1 (CA)
Inventor: PILI ROGER R
IPC: F15B13/04
Filed: 2004-06-02
Abstract: A bi-directional metering valve assembly includes a valve block (46) defining a first port (100) that receives hydraulic fluid from a source, and a second port (98) that directs hydraulic fluid to a load. A rotatable valve member (74) defines first (116) and second (114) apertures in an axial face, communicated by a channel (118) that may be placed in selective communication with the first (100) and second (98) ports, respectively, to direct hydraulic fluid from the source to the load. At least one metering sealing assembly defines a flange (132) that is sized to completely overlap and seal the correxponding aperture (114, 116). The valve member is operable to control the direction of fluid flow, and make fine adjustments to the hydraulic fluid flow rate.
Patent CA-2526395-A1 (CA)
Title: Matching card game
Inventor: HARDIE JEANNIE BURNS
IPC: A63F1/06
Filed: 2004-05-20
Abstract: A card game is provided that includes collection cards (20), point cards (22), and action-altering cards (24). The action-altering cards may include a prevention card (26) that precludes a player from making an otherwise allowed play as long as the action-altering card is possessed by that player. Wild cards (28) may be included and used to complete a set of any of the collection cards. Players trade cards by calling out bids simultaneously and trading that number of cards with a player calling out the same bid. Once a set of collection cards is completed, that player may claim a corresponding point card, unless precluded from doing so by possession of an action~altering card.
Patent CA-2526482-A1 (CA)
Inventor: WRITER MICHELE
IPC: C12N15/861
Filed: 2004-06-07
Abstract: A peptide consisting of or comprising an amino acid sequence selected from a ) Px1X2X3 T [SEQ.ID.NO.:1]; b) PSX4S [SEQ.ID.NO. :2]; C) QX5X6X7Q  [SEQ.ID.NO.:3]; d) SX8S [SEQ-ID.NO.:4], in which X1, X2 and X3, which may be the same or different, each represents an amino acid residue; X2 is preferably N or L; X4 represents an amino acid residue, preferably N or L; X5 and X7, which may be the same or different, each represents an amino acid residue, X6 represents an amino acid residue having an amide side chain; and X8 represent an amino acid having an aliphatic side chain, which peptide binds to dendritic cells and also to other types of cells. The peptide may be used a target non-viral and viral vectors to such cells.